"Sales" require regulatory approval. The good thing about this news is that this site already has experience utilising the device from a prior trial, so we can expect further recruitment of patients in the TRIPP-FFX trial, which from my understanding, would be the next step towards regulatory approval.
Not a bad way to end the year - enjoy a Happy New Year everyone, let's see how 2025 goes for patients and shareholders alike!
"Sales" require regulatory approval. The good thing about this...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.010(1.06%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | $1.02 | 94.0¢ | $110.7K | 114.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15628 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1909 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |